Quantcast

Contract Research Organization WCCT Global Announces Attendance at the 2014 Outsourcing in Clinical Trials West Coast Conference

January 27, 2014

WCCT Global will be at the 2014 Outsourcing in Clinical Trials West Coast to explain exciting new service offerings for 2014

COSTA MESA, Calif., Jan. 27, 2014 /PRNewswire-iReach/ — WCCT Global, a contract research organization headquartered in Southern California, announced today that they will be exhibiting at the Outsourcing in Clinical Trials West Coast conference on January 28(th) – 29(th) in Burlingame, California. WCCT Global is excited to be in attendance because they will be sharing with the industry new services offerings including expanding ophthalmology and aesthetics research capabilities with the acquisition of two new research sites and innovative patient recruitment solutions. OCT West Coast is the perfect opportunity to showcase these capabilities because many of the industry’s top professionals will be in attendance and WCCT Global has undergone tremendous growth that will greatly benefit those that looking for a full service CRO partner or clinical sites. WCCT Global’s VP. of Business Development Talia Nikolao stated, “We are looking forward to attending one of the first industry events of 2014, and to sharing information about our new expanding capabilities in ophthalmology and aesthetic research in addition to the other therapeutic areas we specialize in.” The OCT West Coast is a great place for industry providers to gather to discuss new innovations in the industry and set up strategic partnerships for 2014.

(Photo: http://photos.prnewswire.com/prnh/20140127/MN52429)

About WCCT Global:
WCCT Global is a multi-site, full-service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting-edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you are interested in how WCCT Global can service one of your upcoming clinical studies, Click Here.

Media Contact: Talia Nikolao, WCCT Global, (714) 252-0700 x 2201, Talia.Nikolao@wcct.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE WCCT Global


Source: PR Newswire



comments powered by Disqus